Analysis of inner and outer retinal thickness in patients using hydroxychloroquine prior to development of retinopathy

JAMA Ophthalmology

Volumn 134, Issue 5, 2016, Pages 511-519

  De Sisternes, Luis ^a   Hu, Julia ^a   Rubin, Daniel L ^a,b   Marmor, Michael F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; HYDROXYCHLOROQUINE SULFATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INNER RETINAL THICKNESS; LONG TERM EXPOSURE; LONGEVITY; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; NERVE CELL; OUTER RETINAL THICKNESS; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINA INJURY; RETINAL THICKNESS; RETINOPATHY; SHORT COURSE THERAPY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TIME PERCEPTION; VISUAL ACUITY; VISUAL FIELD;

EID: 84968792205     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2016.0155     Document Type: Article

References (19)

1. Marmor MF. Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol. 2012;130(4):461-469.
2. Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL. Chloroquine retinopathy in the Rhesus monkey. Invest Ophthalmol Vis Sci. 1978;17(12):1158-1175.
3. Pasadhika S, Fishman GA. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. Eye (Lond). 2010;24(2): 340-346.
4. Pasadhika S, Fishman GA, Choi D, Shahidi M. Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity. Eye (Lond). 2010;24(5):756-762.
5. Ulviye Y, Betul T, N ur TH, Selda C. Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquine. Indian J Ophthalmol. 2013;61 (4):168-171.
6. De Sisterne s L, Hu J, Rubin DL, Marmor MF. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: Inner versus outer retina, parafovea versus peripheral fovea. Invest Ophthalmol Vis Sci. 2015;56 (5):3415-3426.
7. Lee HJ, Kim MS, Jo YJ, Kim JY. Thickness of the macula, retinal nerve fiber layer, and ganglion cell layer in the epiretinal membrane: The Repeatability Study of Optical Coherence Tomography. Invest Ophthalmol Vis Sci. 2015;56(8):4554-4559.
8. Lee HJ, Kim MS, Jo YJ, Kim JY. Ganglion cell-inner plexiform layer thickness in retinal diseases: Repeatability Study of Spectral-Domain O ptical Coherence Tomography. Am J Ophthalmol. 2015;160(2):283-289.e1.
9. De Sisternes L, Hu J, Rubin DL, Leng T. Visual prognosis of eyes recovering from macular hole surgery through automated qu antitative analysis of spectral-domain optical coherence tomography (SD-OCT) scans. Invest Ophthalmol Vis Sci. 2015;56 (8):4631-4643.
10. Song WK, Lee SC, Lee ES, Kim CY, Kim SS. Macular thickness variations with sex, age, and axial length in healthy subjects: A spectral domain-optical coherence tomography study. Invest Ophthalmol Vis Sci. 2010;51(8):3913-3918.
11. Liu T,HuAY, Kaines A, Yu F, Schwartz SD, Hubschman JP. A pilot study of normative data for macular thickness and volume measurements using Cirrus high-definition optical coherence tomography. Retina. 2011;31(9):1944-1950.
12. Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132(12):1453-1460.
13. Lee MG, Kim SJ, Ham DI, et al. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy. Invest Ophthalmol Vis Sci. 2015;56(1):396-402.
14. Greenstein VC, Amaro-Quireza L, Abraham ES, Ramachandran R, Tsang SH, Hood DC. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy. Doc Ophthalmol. 2015;1 30(1):13-23.
15. Marmor MF, Melles RB. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy. Ophthalmology. 2014;121(6):1257-1262.
16. Kellner S,Weinitz S, Kellner U. Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence. Br J Ophthalmol. 2009;93(11):1444-1447.
17. Melles RBMarmor MF. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity. Ophthalmology. 2015, 122, 1, 110-116
18. Marmor MF, Hu J. Effect of disease stage on progression of hydroxychloroquine retinopathy. JAMA Ophthalmol. 2014;132(9):1105-1112.
19. Marmor MF, Kellner U, Lai TY, Melles RB, Meiler WF. AAO statement: Recommendations on screening for chloroquine and hydroxychloroquine retinopathy ophthalomology (2016 revision). Ophthalmology. In press.